Clinical Trials Logo

Smoking Behaviors clinical trials

View clinical trials related to Smoking Behaviors.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06373679 Not yet recruiting - Cigarette Smoking Clinical Trials

Switch or Quit R01

Start date: May 2024
Phase: N/A
Study type: Interventional

This study evaluates whether non-cigarette tobacco products (e-cigarettes) can help smokers quit smoking as compared to traditional quit methods (nicotine replacement therapy or varenicline/Chantix). Participants in this study will be randomly assigned to one of two groups, then will have a choice between the offered products of that group. Participants in the e-cigarette group will have a choice of e-cigarette brand and flavor. Participants in the medication group will have choice between nicotine replacement therapy (patches and lozenges) or varenicline, also known as Chantix. Participation will last 6 months and will include weekly phone calls for the initial 7-weeks plus a 11-week phone call and a 6-month follow-up visit. Participants will also complete electronic daily diaries during the first 7-weeks.

NCT ID: NCT05959512 Not yet recruiting - Smoking Behaviors Clinical Trials

Smoking Pattern and Influencing Factors in Hospitalized Patients

Start date: July 19, 2023
Phase:
Study type: Observational

This study examines the smoking patterns and determinants of inpatients who smoke, develops tailored smoking cessation interventions based on their individual needs, and aims to enhance the effectiveness of quitting and lower the likelihood of relapse.

NCT ID: NCT05704231 Not yet recruiting - Self Efficacy Clinical Trials

The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

This study will be carried out to examine the effect of telephone-assisted smoking cessation program on self-efficacy, smoking behavior, tumor recurrence and progression in patients with non-muscle invasive bladder cancer.

NCT ID: NCT05484505 Not yet recruiting - Smoking Cessation Clinical Trials

Preloaded Combination Nicotine Replacement Therapy on Smoking Cessation of Adult Population in Kazakhstan

Start date: July 1, 2023
Phase: Early Phase 1
Study type: Interventional

Randomized, controlled, two-armed, single-blinded, superiority trial with 1:1 allocation ratio Nicotine Replacement Therapy(NRT)

NCT ID: NCT05442294 Not yet recruiting - Adolescent Behavior Clinical Trials

"Juego de LLaves": Study Protocol of a Universal School-based Drug Use Prevention Program (PSIDUP)

PSIDUP
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

"Juego de Llaves" is a universal school-based drug prevention program for adolescents aged 12-15 years. The outcome evaluation is critical to determine the quality of preventive interventions. This protocol describes the full protocol of the evaluation design, instruments, randomization procedure, follow-ups, and primary outcomes. Method: Non-Randomized Control Cluster Trial in a set of Spanish school centers at the compulsory secondary education level, with follow-ups at 12-, 24- and 36-months. Participants will be allocated to an experimental or control (no intervention) group. Using an electronic ad-hoc designed App, a battery of instruments will be used to assess addictive behaviors, sociodemographic variables, school climate and other transdiagnostic psychological variables. A piloting test will be conducted to test the implementation protocol and to calculate the sample size needed for the outcome evaluation. After implementing the program, longitudinal statistical approaches will be used to inform on the intervention efficacy and potential moderators and mediators. There is a lack of effectiveness assessments of school prevention programs, and it is expected that this protocol will expedite the monitoring and ongoing evaluation in prevention.

NCT ID: NCT04891939 Not yet recruiting - Smoking Cessation Clinical Trials

Development and Assessment of a Teacher-led Intervention in Preventing Tobacco Use Among the Youth in Ghana

Start date: June 2021
Phase: N/A
Study type: Interventional

The main purpose of this experimental study is to compare the existing health education program for School Health and Education Program (SHEP) in the Junior High Schools with a new health education model (Smart-Kids') for the prevention of smoking initiation and to improve the quit rate among students in Upper East Region of Ghana. The intervention will be based on the Theory of Triadic Influences (TTI) which involves the cultural environment in which adolescents mature, their immediate social situation, and intrapersonal differences. These three factors impact through different mediating variables, such as attitudes, normative beliefs, and self-efficacy, which eventually affect smoking intentions and smoking behavior as the outcome measures. The study design is a cluster randomized control trial. After baseline assessment, the investigators will randomize schools to receive the new health education for three months whiles the comparator (control group) will continue with the usual health education. The investigators will conduct a post-intervention assessment using the same questionnaire with unique identity codes linking each participant to their baseline assessments immediately at the end of the intervention. Final assessment will be done approximately three months after the intervention. The investigators will assess and compare the effectiveness of the new health model to the normal health promotion programs (SHEP). The investigators hypothesized that there will be no significant differences observed between the new teacher-led health education program (the Smart-Kids Program) and the existing SHEP coordinator-led in preventing smoking uptake among the youth. Alternatively, the new teacher-led health education program would facilitate the effects of the program on outcomes. on four key primary endpoints as follows: - H1: The intervention study will result in a 30% reduction in smoking uptake - H2: The intervention study will result in a 10% reduction in smokers - H3. The intervention will increase knowledge of the harmful effects of tobacco use by 50% - H4. The intervention will increase the willingness to quit smoking by 10% among smokers